Obama's Commitment to Scientific Integrity

President Obama has made it clear that, when creating policy, his administration will hold science over political ideology and value the input of people like you.

TAKE ACTION NOW to demand the Obama Administration honor these words when considering policy on medical marijuana policies!

There is a scientific consensus that cannabis can control symptoms of serious and chronic illness. In the past decade alone, clinical research has demonstrated that cannabis and its constituents can safely and effectively treat nausea and vomiting, loss of appetite, pain and spasticity. And a growing body of literature suggests that cannabis may hold the key to unlocking new treatments for HIV/AIDS, Multiple Sclerosis, cancer, and many other conditions. Year after year, the research has been twisted or ignored to suit a political ideology.

The federal government is lying when it states that the therapeutic use of cannabis has no accepted medical value in treatment in the United States and ASA, time and again, has called them to task on this lie. Now, we need YOU to weigh in!

Last month, the President signed a Memorandum on Scientific Integrity affirming that policy decisions that are made are done so with facts and data, not political agendas. Yesterday, the Office of Technology and Science Policy (OTSP), the agency responsible for overseeing the scientific integrity pledge, created a way for you to provide feedback.

This is your chance to tell the White House what you think about the Government’s long-standing refusal to acknowledge the medical benefits of cannabis and its obstruction of medical cannabis research.

Visit www.AmericansForSafeAccess.org/ScientificIntegrity and choose one of the following three options to comment on Sections C and D:

1. The U.S Department of Health and Human Services must correct statements disseminated on federal websites and in the Federal Register that falsely declare that cannabis “has no currently accepted medical use in treatment in the United States."
2. The U.S. Drug Enforcement Administration must accept the Administrative Law Judge Bittner’s February 2007 Opinion and Recommended Ruling in the matter of Lyle E. Craker, Ph.D., Docket No. 05-16, to grant a competitive bulk-manufactures license to establish a privately-funded facility to cultivate cannabis exclusively for clinical research.
3. The U.S. Department of Justice must remove cannabis from the list of Schedule I controlled substances in light of a growing body of research, including four double-blind placebo controlled clinical trials, which supports the therapeutic use of cannabis and in accordance with DEA’s own 1988 Administrative Law ruling in which Judge Young opined that “the provisions of the CSA permit and require the transfer of cannabis from schedule I to schedule II."

We have got to make it clear that science and research show that cannabis has medical value and we expect the President’s policy on medical cannabis to reflect that.

Two plus two equals four - NOT five!

When you’re done – send this alert to your email networks to spread the word! Let’s send a message that we expect science to rule out!